Alar Pharmaceuticals Inc.
6785
Rank in Stocks
#17833
Alar Pharmaceuticals Inc., a drug development company, focuses on developing... Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
Share Price
$2.30
Last synced: 2026-11-10
Market Cap
$153.75M
Change (1 day)
-1.31%
Change (1 year)
-72.88%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Alar Pharmaceuticals Inc. (6785)
Category
Healthcare
Operating Margin for Alar Pharmaceuticals Inc. (6785)
Operating Margin as of November 2026 TTM: -5,708.40%
According to Alar Pharmaceuticals Inc.'s latest financial reports, its current operating margin (TTM) is -5,708.40%. At the end of 2025 the company had an operating margin of -6,095.10%.
Operating Margin history for Alar Pharmaceuticals Inc. from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -5,708.40% | -6.34% |
| 2025 | -6,095.10% | 421.83% |
| 2024 | -1,168.02% | -1,521.81% |
| 2023 | 82.15% | -101.41% |
| 2022 | -5,815.88% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -28,460.83% | 0.00% |
| 2019 | 0.00% | -100.00% |
| 2018 | -14,188.60% | 311.14% |
| 2017 | -3,451.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 62.34% | -100.01% |
US
|
|
| 31.60% | -100.01% |
SE
|
|
| 30.13% | -100.01% |
FR
|
|
| 29.76% | -100.01% |
HK
|
|
| 30.46% | -100.01% |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Alar Pharmaceuticals Inc.'s operating margin
What is Alar Pharmaceuticals Inc.'s operating margin?
Alar Pharmaceuticals Inc.'s operating margin is -5,708.40%, as of Nov 2026.
What was Alar Pharmaceuticals Inc.'s operating margin in 2025?
In 2025, Alar Pharmaceuticals Inc.'s operating margin was -6,095.10%, compared with -1,168.02% in 2024.
How has Alar Pharmaceuticals Inc.'s operating margin changed since 2020?
From 2020 to 2025, Alar Pharmaceuticals Inc.'s operating margin was highest in 2023 (82.15%) and lowest in 2020 (-28,460.83%).
How does Alar Pharmaceuticals Inc.'s operating margin compare with similar companies?
Alar Pharmaceuticals Inc.'s operating margin (-5,708.40%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 62.34%.